Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Equity Average (2016 - 2025)

Rockwell Medical's Equity Average history spans 15 years, with the latest figure at $37.0 million for Q4 2025.

  • For Q4 2025, Equity Average rose 19.9% year-over-year to $37.0 million; the TTM value through Dec 2025 reached $37.0 million, up 19.9%, while the annual FY2025 figure was $34.8 million, 29.12% up from the prior year.
  • Equity Average reached $37.0 million in Q4 2025 per RMTI's latest filing, up from $33.7 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $37.0 million in Q4 2025 to a low of -$1.1 million in Q1 2022.
  • Average Equity Average over 5 years is $20.4 million, with a median of $21.2 million recorded in 2023.
  • Peak YoY movement for Equity Average: plummeted 103.76% in 2022, then skyrocketed 1272.89% in 2023.
  • A 5-year view of Equity Average shows it stood at $6.8 million in 2021, then skyrocketed by 121.89% to $15.1 million in 2022, then soared by 41.55% to $21.4 million in 2023, then surged by 44.18% to $30.9 million in 2024, then increased by 19.9% to $37.0 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Equity Average are $37.0 million (Q4 2025), $33.7 million (Q3 2025), and $31.0 million (Q2 2025).